EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in the Anti-Atherosclerotic Mechanisms of Epigallocatechin Gallate

Yihui Liu, Yiling Long, Jun Fang, Gang Liu

Nutrients · 28.06.2024 · 16 (13) · 2074

DOI: 10.3390/nu16132074 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 28.06.2024. Verfasst von Yihui Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China. Hauptthemen laut MEDLINE: Catechin, Atherosclerosis, Lipid Metabolism. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis (AS) is a common clinical sickness and the major pathological basis of ischemic cardiocerebrovascular diseases (CCVDs). The pathogenesis of AS involves a variety of risk factors, and there is a lack of effective preventive and curative drugs that can completely treat AS. In recent years, with the improvement of people’s living standards and changes in dietary habits, the morbidity and mortality rates of AS are on the rise, and the age of onset tends to be younger. The formation of AS is closely related to a variety of factors, and the main factors include lipid metabolism disorders, endothelial damage, inflammation, unstable plaques, etc. Epigallocatechin gallate (EGCG), as one of the main components of catechins, has a variety of pharmacological effects, and its role in the prevention of AS and the protection of cardiovascular and cerebral blood vessels has been highly valued. Recent epidemiological investigations and various in vivo and ex vivo experiments have shown that EGCG is capable of resisting atherosclerosis and reducing the morbidity and mortality of AS. In this paper, we reviewed the anti-AS effects of EGCG and its mechanisms in recent years, including the regulation of lipid metabolism, regulation of intestinal flora disorders, improvement of vascular endothelial cell functions, inhibition of inflammatory factors expression, regulation of inflammatory signaling pathways, inhibition of matrix metalloproteinase (MMP) expression, and inhibition of platelet aggregation, which are helpful for the prevention of cardiocerebrovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CatechinAtherosclerosisLipid MetabolismHumansAnimalsGastrointestinal Microbiome

Stichwörter der Autor:innen

EGCGatherosclerosiscardiocerebrovascular diseasesmechanisms

Substanzen

Catechinepigallocatechin gallate

Autor:innen und Institutionen

  • College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.

Förderung

  • Hunan Provincial Science and Technology Department

Zitieren

APA

Liu, Y., Long, Y., Fang, J., & Liu, G. (2024). Advances in the Anti-Atherosclerotic Mechanisms of Epigallocatechin Gallate. Nutrients, 16(13), 2074. https://doi.org/10.3390/nu16132074

Vancouver

Liu Y, Long Y, Fang J, Liu G. Advances in the Anti-Atherosclerotic Mechanisms of Epigallocatechin Gallate. Nutrients. 2024;16(13):2074. doi:10.3390/nu16132074

BibTeX
@article{Liu2024,
  author = {Liu, Yihui and Long, Yiling and Fang, Jun and Liu, Gang},
  title = {Advances in the Anti-Atherosclerotic Mechanisms of Epigallocatechin Gallate},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {13},
  pages = {2074},
  doi = {10.3390/nu16132074}
}
Kostenlos starten →